Clinical Trials
3 trialsNCT01332617 2017-12-29
Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
University of Louisville
Phase 2 Withdrawn
NCT00503763 2015-04-16
PSMMSS
Meir Medical Center
Phase 2 Withdrawn
NCT00399867 2006-12-20
Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
Ludwig-Maximilians - University of Munich
Phase 2 Completed